Medication adherence and persistence: A comprehensive review

Advances in Therapy

Volumn 22, Issue 4, 2005, Pages 313-356

  Krueger, Kem P ^a   Berger, Bruce A ^b   Felkey, Bill ^c  

^a UNIVERSITY OF WYOMING   (United States)

^b Department of Pharmacy Care Systems ^*  (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Adherence; Behavioral change; Intervention; Model; Persistence

Indexed keywords

BEHAVIOR CHANGE; CULTURAL FACTOR; DOCTOR PATIENT RELATION; HEALTH CARE; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; MODEL; PATIENT COMPLIANCE; REVIEW; RISK BENEFIT ANALYSIS; SELF CARE; SOCIAL PSYCHOLOGY; THEORY; TREATMENT PLANNING;

EID: 29344456174     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850081     Document Type: Review

References (196)

1. Demyttenaere K. Noncompliance with antidepressants: who's to blame? Int Clin Psychopharmacol. 1998;13(suppl 2):S19-S25.
2. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Nat Cancer Inst. 2002;94:652-661.
3. Schoen MD, DiDomenico RJ, Connor SE, Dischler JE, Bauman JL. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy. 2001;21: 1455-1463.
4. Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc. 1998;38:574-585.
5. Miura T, Kojima R, Mizutani M, Shiga Y, Takatsu F, Suzuki Y. Effect of digoxin noncompliance on hospitalisation and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Eur J Clin Pharmacol. 2001;57:77-83.
6. Sellwood W, Tarrier N. Demographic factors associated with extreme non-compliance in schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 1994;29:172-177.
7. Lesaffre E, Kocmanova D, Lemos PA, Disco CM, Serruys PW. A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS. Clin Ther. 2003; 25:2431-2447.
8. Balkrishnan R, Christensen DB. Inhaled corticosteroid nonadherence and immediate avoidable medical events in older adults with chronic pulmonary ailments. J Asthma. 2000;37:511-517.
9. Lecompte D, Pelc I. A cognitive-behavioral program to improve compliance with medication in patients with schizophrenia. Int J Ment Health. 1996;25:51-56.
10. Rzewuska M. Drug maintenance treatment compliance and its correlation with the clinical picture and course of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 26:811-814.
11. Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ. 1996;312:345-349.
12. Lin EH, Von Korff M, Ludman EJ, et al. Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry. 2003;25:303-310.
13. Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry. 2003;60:904-912.
14. Rapoff MA, Belmont J, Lindsley C, Olson N, Morris J, Padur J. Prevention of nonadherence to nonsteroidal anti-inflammatory medications for newly diagnosed patients with juvenile rheumatoid arthritis. Health Psych. 2002;21:620-623.
15. Razali SM, Hasanah CI, Khan UA, Subramaniam M. Psychosocial interventions for schizophrenia. Ment Health. 2000;9:283-289.
16. Saunders B, Wilkinson C, Phillips M. The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction. 1995;90:415-424.
17. Margolin A, Avants S, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol 2003; 22:223-228.
18. Schaffer SD, Tian L. Promoting adherence: effects of theory-based asthma education. Clin Nurs Res. 2004;13:69-89.
19. Schmaling KB, Blume AW, Afari N. A randomized controlled pilot study of motivational interviewing to change attitudes about adherence to medications for asthma. J Clin Psychol Med Settings. 2001;8:167-172.
20. Ngoh LN, Shepherd, MD. Design, development, and evaluation of visual aids for communicating prescription drug instructions to nonliterate patients in rural Cameroon. Patient Educ Couns. 1997; 31:245-261.
21. Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoe AW, Leufkens HG. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Cardiac Fail. 2003;9:404-411.
22. Cramer JA, Rosenheck R. Enhancing medication compliance for people with serious mental illness. J Nerv Ment Dis. 1999;187:53-55.
23. Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58:241-247.
24. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273:1026-1031.
25. Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counseling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ. 1999;319:612-615.
26. Tan AS, Yong LS, Wan S, Wong ML. Patient education in the management of diabetes mellitus. Singapore Med J. 1997;38:156-160.
27. Rand CS, Nides M, Cowles MK, Wise RA, Connett J. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1995;152: 580-588.
28. Dixon L, Weiden P, Torres M, Lehman A. Assertive community treatment and medication compliance in the homeless mentally ill. Am J Psychiatry. 1997;154:1302-1304.
29. Gani F, Pozzi E, Crivellaro MA, et al. The role of patient training in the management of seasonal rhinitis and asthma: clinical implications. Allergy. 2001;56:65-68.
30. Lowe CJ, Raynor DK, Purvis J, Farrin A, Hudson J. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol. 2000;50:172-175.
31. Piette JD, Weinberger M, McPhee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med. 2000;108:20-27.
32. Stewart AV, Eales CJ, Davis KA. Effect of a telephonic intervention on the adherence of patients with hypertension. S Afr J Physiother. 2003;5:29-36.
33. Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25:218-226.
34. Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999;19:860-869.
35. Bukstein DA, Bratton DL, Firriolo KM, et al. Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with oral montelukast or inhaled cromolyn: a randomized, open-label, crossover study. J Asthma. 2003;4:475-485.
36. Doren M, Reuther G, Minne HW, Schneider HP. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol. 1995;173:1446-1451.
37. Laine L, Estrada R, Trujillo M, Fukanaga K, Neil G. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther. 1996;10:1029-1033.
38. Mounier-Vehier C, Bernaud C, Carre A, Lequeuche B, Hotton JM, Charpentier JC. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release. Am J Hypertens. 1998;11(4 pt 1):478-486.
39. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol. 2004;113:245-251.
40. Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail. 2003;9:324-332.
41. Azrin NH, Teichner G. Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behav Res Ther. 1998;36:849-861.
42. Frick PA, Lavreys L, Mandaliya K, Kreiss JK. Impact of an alarm device on medication compliance in women in Mombasa, Kenya. Inter J STD AIDS. 2001;12:329-333.
43. Hoffman L, Enders J, Luo J, Segal R, Pippins J, Kimberlin C. Impact of an antidepressant management program on medication adherence. Am J Manag Care. 2003;9:70-80.
44. Jacobson TA, Thomas DM, Morton FJ, Offutt G, Shevlin J, Ray S. Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates: a randomized controlled trial. JAMA. 1999;28:646-650.
45. Laster SF, Martin JL, Fleming JB. The effect of a medication alarm device on patient compliance with topical pilocarpine. J Am Optom Assoc. 1996;67:654-658.
46. Perri M, Martin BC, Pritchard FL. Improving medication compliance: a practical intervention. J Pharm Technol. 1995;11:167-172.
47. Lipton HL, Bird JA. The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomized controlled trial. Gerontologist. 1994;34:307-315.
48. Naunton M, Peterson GM. Evaluation of home-based follow-up of high-risk elderly patients discharged from hospital. J Pharm Pract Res. 2003;33:176-182.
49. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101: 270-276.
50. Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn H. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. Br J Clin Pharmacol. 1997;44:163-165.
51. Lee M, Kemp JA, Canning A, Egan C, Tataronis G, Farraye FA. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med. 1999;159:2312-2316.
52. Okonkwo PO, Akpala CO, Okafor HU, Mbah AU, Nwaiwu O. Compliance to correct dose of chloroquine in uncomplicated malaria correlates with improvement in the condition of rural Nigerian children. Trans R Soc Trop Med Hyg. 2001;95:320-324.
53. Putnam DE, Finney JW, Barkley PL, Bonner MJ. Enhancing commitment improves adherence to a medical regimen. J Consul Clin Psychol. 1994;62:191-194.
54. Berg J, Dunbar-Jacob J, Sereika SM. An evaluation of a self-management program for adults with asthma. Clin Nurs Res. 1997;6:225-238.
55. Lowe CJ, Raynor DK, Courtney EA, Purvis J, Teale C. Effects of self medication programme on knowledge of drugs and compliance with treatment in elderly patients. BMJ. 1995;310:1229-1231.
56. Mehta S, Moore RD, Graham, NM. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11:1665-1670.
57. Venturini F, Nichol MB, Sung JC, Bailey KL, Cody M, McCombs JS. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother. 1999;33:281-288.
58. Van Servellen G, Carpio F, Lopez M, et al. Program to enhance health literacy and treatment adherence in low-income HIV-infected Latino men and women. AIDS Patient Care STDs. 2003; 17:581-594.
59. Agarwal MR, Sharma VK, Kishore Kumar KV, Lowe D. Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Social Psychiatry. 1998;44:92-106.
60. Branin, JJ. Correlates of Strategy Use in Medication Adherence Among Older Adults [dissertation]. Claremont, Calif: Claremont Graduate University; 2003.
61. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand. 2002;106:286-290.
62. Daniels DE, Rene AA, Daniels VR. Race: an explanation of patient compliance-fact or fiction? J Nat Med Assoc. 1994;86:20-25.
63. Degli Esposti E, Sturani A, Di Martino M, et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens. 2002;16:439-444.
64. Peters KF, Horne R, Kong F, Francomano CA, Biesecker BB. Living with Marfan syndrome, II: medication adherence and physical activity modification. Clin Genet. 2001;60:283-292.
65. Van Servellen G, Brown JS, Lombardi E, Herrera G. Health literacy in low-income Latino men and women receiving antiretroviral therapy in community-based treatment centers. AIDS Patient Care STDs. 2003;17:283-298.
66. Wagner GJ. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDs. 2002;16:599-608.
67. Ayres A, Hoon PW, Franzoni JB, et al. Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J Psychosom Res. 1994;38:393-402.
68. Brus H, van de Laar M, Taal E, Rasker J, Wiegman O. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Counsel. 1999;36:57-64.
69. Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry. 2000;61:549-555.
70. Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther. 1994;16:110-117.
71. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant. 1996;15:631-645.
72. Erlen JA, Sereika SM, Cook RL, Hunt SC. Adherence to antiretroviral therapy among women with HIV infection. J Obstet Gynecol Neonatal Nurs. 2002;31:470-477.
73. Evangelista L, Doering LV, Dracup K, Westlake C, Hamilton M, Fonarow, GC. Compliance behaviors of elderly patients with advanced heart failure. J Cardiovasc Nurs. 2003;18:197-206.
74. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929-2933.
75. Kyngas H. Compliance with health regimens of adolescents with epilepsy. Seizure. 2000;9: 598-604.
76. Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14:267-273.
77. Gago C, Gruss E, Gonzalez S, et al. Compliance of haemodialysis patients with prescribed medication. EDTNA ERCA J. 2000;26:4-6.
78. Asawavichienjinda T, Sitthi-Amorn C, Tanyanont W. Compliance with treatment of adult epileptics in a rural district of Thailand. J Med Assoc Thail. 2003;86:46-51.
79. Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Nat Med Assoc. 1999;91:439-446.
80. Miller LG, Liu H, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis. 2003;36:514-518.
81. Wagner G. Placebo practice trials: the best predictor of adherence readiness for HAART among drug users? HIV Clin Trials. 2003;4:269-281.
82. Pettinger MB, Waclawiw MA, Davis KB, et al. Compliance to multiple interventions in a high risk population. Ann Epidemiol. 1999;9:408-418.
83. Van Servellen G, Chang B, Garcia L, Lombardi E. Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women. AIDS Patient Care STDs. 2002;16:269-281.
84. Cohen I, Rogers P, Burke V, Beilin LJ. Predictors of medication use, compliance and symptoms of hypotension in a community-based sample of elderly men and women. J Clin Pharm Ther. 1998;23:423-432.
85. Embry LM. Predictors of Treatment Adherence in Pediatric Cancer Patients [dissertation]. Hattiesburg, Miss: University of Southern Mississippi; 2003.
86. Eddy ME, Carter BD, Kronenberger WG, et al. Parent relationships and compliance in cystic fibrosis. J Pediatr Health Care. 1998;12:196-202.
87. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDs. 1999;13:185-197.
88. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of adherence to antiretroviral therapy. J AIDS. 2001;28:47-58.
89. Anastasio GD, Little JM Jr, Robinson MD, Pettice YL, Leitch BB, Norton HJ. Impact of compliance and side effects on the clinical outcome of patients treated with oral erythromycin. Pharmacotherapy. 1994;14:229-234.
90. Bruckert E, Simonetta C, Giral P. Compliance with fluvastatin treatment: characterization of the noncompliant population within a population of 3845 patients with hyperlipidemia. CREOLE Study Team. J Clin Epidemiol. 1999;52:589-594.
91. Fraser C, Hadjimichael O, Vollmer T. Predictors of adherence to copaxone therapy in individuals with relapsing-remitting multiple sclerosis. J Neurosci Nurs. 2001;33:231-239.
92. Cooper AE, Hanrahan P, Luchins DJ. Compliance with atypical antipsychotic regimens. Drug Benefit Trends. 2003;15:34-38.
93. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14:88-90.
94. Carrieri MP, Chesney MA, Spire B, et al. Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. Inter J Behav Med. 2003;10:1-14.
95. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS Care. 1999;13:1763-1769.
96. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. 1997; 54:531-533.
97. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002; 17:504-511.
98. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly, what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51:615-622.
99. Cuffel BJ, Alford J, Fischer EP, Owen RR. Awareness of illness in schizophrenia and outpatient treatment adherence. J Nerv Ment Dis. 1996;84:653-659.
100. Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res. 2003;63:49-58.
101. Conway SP, Pond MN, Hamnett T, Watson A. Compliance with treatment in adult patients with cystic fibrosis. Thorax. 1996;51:29-33.
102. Walsh JC, Home R, Dalton M, Burgess AP, Gazzard BG. Reasons for non-adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes. AIDS Care. 2001;13:709-720.
103. Auamnoy T. Self-efficacy and Non-adherence in Post-renal Transplant Patients [dissertation]. Iowa City, Iowa: University of Iowa; 2000.
104. Christensen AJ, Moran PJ, Lawton WJ, Stallman D, Voigts AL. Monitoring attentional style and medical regimen adherence in hemodialysis patients. Health Psych. 1997;16:256-262.
105. Dodds JA. Anger, Hostility and Psychological Reactance: Implications for Intervention and Medical Adherence in the Coronary Patient [dissertation]. Kent, Ohio: Kent State University; 1997.
106. Penkower L, Dew MA, Ellis D, Sereika SM, Kitutu JM, Shapiro R. Psychological distress and adherence to the medical regimen among adolescent renal transplant recipients. Am J Transplant. 2003;3:1418-1425.
107. Duncan JC, Rogers R. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders. J Forensic Sci. 1998; 43:1133-1137.
108. Patton K, Meyers J, Lewis BE. Enhancement of compliance among patients with hypertension. Am J Manag Care. 1997;3:1693-1698.
109. Laidlaw JK, Beeken JE, Whitney FW, Reyes AA. Contracting with outpatient hemodialysis patients to improve adherence to treatment. Anna J. 1999;26:37-40.
110. Segal E, Tamir A, Ish-Shalom S. Compliance of osteoporotic patients with different treatment regimens. Isr Med Assoc J. 2003;5:859-862.
111. Malcolm SE, Ng JJ, Rosen RK, Stone VE. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care. 2003;15:251-261.
112. McDonald-Miszczak L, Maki SA, Gould ON. Self-reported medication adherence and health status in late adulthood: the role of beliefs. Exp Aging Res. 2000;26:189-207.
113. Budd RJ, Hughes IC, Smith JA. Health beliefs and compliance with antipsychotic medication. Br J Clin Psychol. 1996;35:393-397.
114. Hargrave R, Remler MP. Noncompliance. J Nat Med Assoc. 1996;88:7,11.
115. Lin CC, Liang CC. The relationship between health locus of control and compliance of hemodialysis patients. Kaohsiung J Med Sci. 1997;13:243-254.
116. Demyttenaere K, Mesters P, Boulanger B, et al. Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine. J Affect Disord. 2001;65:243-252.
117. Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990;19:279-290.
118. Home R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care. 2001;10:135-140.
119. Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12:387-398.
120. Breen R, Thornhill JT. Noncompliance with medication for psychiatric disorders: reasons and remedies. CNS Drugs. 1998;9:457-471.
121. Ciechanowski PS, Katon WJ, Russo JE, Walker EA. The patient-provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry. 2001;158:29-35.
122. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication non-compliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000; 51:216-222.
123. Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther. 2002;18:401-409.
124. Hausman A. Taking your medicine: relational steps to improving patient compliance. Health Market Q. 2001;19:49-71.
125. Chadwick NB. The Therapeutic Alliance, Awareness, and Medication Compliance in the Treatment of Schizophrenia [dissertation]. Augusta, Ga: Medical College of Georgia; 2001.
126. Fenichel A. The Relationship Between Health Care Clinicians' Relational Abilities and Psychosocial Orientation to Patient Care, and Patient Adherence With Medical Treatment [dissertation]. New York, NY: Columbia University; 1999.
127. Levine AM. Antiretroviral therapy: adherence. Clin Care Options HIV Online J. 1998;4:1-10.
128. Isaac LM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. Gerontologist. 1993; 33:772-781.
129. Kasl SA, Cobb S. Health behavior, illness behavior, and sick role behavior, I: health and illness behavior. Arch Environ Health. 1966;12:246-266.
130. Carroll KM, Ball SA, Nich C, et al. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry. 2001;58:755-761.
131. Cox LE. The Relative Influence of Social Support on the Medication Compliance of People With HIV Infection [dissertation]. Richmond, Va: Virginia Commonwealth University; 1998.
132. Moore SJ. Individuals' Beliefs Concerning Adherence to Prescribed Antihypertensive Medication Regimens [dissertation]. Bloomington, Ind: Indiana University School of Nursing; 1995.
133. Bastardo YM, Kimberlin CL. Predicting adherence to antiretroviial therapy, an application of an extended theory of reasoned action (APS-P-203). International Pharmaceutical Federation-World Congress. 2002;62:73.
134. Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 2000;101:119-124.
135. Cohen NL, Parikh SV, Kennedy SH. Medication compliance in mood disorders: relevance of the health belief model and other determinants. Prim Care Psychiatry. 2000;6:101-110.
136. Scott J. Using health belief models to understand the efficacy-effectiveness gap for mood stabilizer treatments. Neuropsychobiology. 2002;46(suppl 1):13-15.
137. Steele RG, Anderson B, Rindel B, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001;13:617-629.
138. Dracup KA, Meleis AI. Compliance: an interactionist approach. Nurs Res. 1982;31:31-36.
139. Christensen AJ, Wiebe JS, Lawton WJ. Cynical hostility, powerful others control expectancies, and patient adherence in hemodialysis. Psychosom Med. 1997;59:307-312.
140. Berg J. An Evaluation of a Self-management Program for Adults With Asthma [thesis]. Pittsburgh, Pa: University of Pittsburgh; 1995.
141. Willey C, Redding C, Stafford J, et al. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther. 2000:22:858-871.
142. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed. New York, NY: The Guilford Press; 2002.
143. Berger BA, Hudmon KS, Liang H. Predicting treatment discontinuation among patients with multiple sclerosis: application of the transtheoretical model of change. J Am Pharm Assoc. 2004; 44:45-545.
144. O'Donnell C, Donohoe G, Sharkey L, et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ. 2003;327:834-838.
145. Sellwood W, Barrowclough C, Tarrier N, Quinn J, Mainwaring J, Lewis S. Needs-based cognitive-behavioural family intervention for carers of patients suffering from schizophrenia: 12-month follow-up. Acta Psychiatr Scand. 2001;104:346-355.
146. Kutcher S, Leblanc J, Maclaren C, Hadrava V. A randomized trial of a specific adherence enhancement program in sertraline-treated adults with major depressive disorder in a primary care setting. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:591-596.
147. Rawlings MK, Thompson MA, Farthing CF, et al. Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/ abacavir regimen in underrepresented HIV-infected patients. J Acquir Immune Defic Syndr. 2003;34:174-183.
148. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA. 2002;288:1594-1602.
149. Capoccia KL, Boudreau DM, Blough DK, et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health-Syst Pharm. 2004;61: 364-372.
150. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428-437.
151. Owens D, Carroll A, Fattah S, Clyde Z, Coffey I, Johnstone E. A randomized, controlled trial of a brief interventional package for schizophrenic out-patients. Acta Psychiatr Scand. 2001; 103:362-369.
152. Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Amer J Health-Syst Pharm. 2003;60:1123-1129.
153. Volume CI, Farris KB, Kassam R, Cox CE, Cave A. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc. 2001;41:411-420.
154. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-1310.
155. Esposito L. The effects of medication education on adherence to medication regimens in an elderly population. J Adv Nurs. 1995;21:935-943.
156. Madoff SA, Pristach CA, Smith CM, Pristach EA. Computerized medication instruction for psychiatric inpatients admitted for acute care. MD Comput. 1996;13:427-431, 441.
157. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H. A pharmacy discharge plan for hospitalized elderly patients: a randomized controlled trial. Age Ageing. 2001;30:33-40.
158. Williford SL, Johnson DF. Impact of pharmacist counseling on medication knowledge and compliance. Mil Med. 1995;160:561-564.
159. Bennett JW, Glasziou P, Del Mar C, De Looze F. A computerized prescribing decision support system to improve patient adherence with prescribing: a randomized controlled trial. Austr Fam Physician. 2003;32:667-671.
160. Cegala DJ, Marinelli T, Post D. The effects of patient communication skills training on compliance. Arch Fam Med. 2000;9:57-64.
161. Lourens H, Woodward MC. Impact of a medication card on compliance in older people. Aust J Ageing. 1994;13:72-76.
162. Stevens VJ, Shneidman RJ, Johnson RE, Boles M, Steele PE, Lee NL. Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention. West J Med. 2002;176:92-96.
163. Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Controlled Clin Trials. 1997;18:187-203.
164. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Counsel. 2002;46:93-108.
165. Krueger KP, Felkey BG, Berger BA. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. J Am Pharm Assoc. 2003;43:668-678.
166. IOM Committee on Health and Literacy. The extent and associations of limited health literacy. In: Nielsen-Bohlman L, Panzer AM, Kindig DA, eds. Health Literacy: A Prescription to End Confusion. Washington, DC: National Academies Press; 2004:59-107.
167. Ebrahimzadeh H, Davalos R, Lee PP. Literacy levels of ophthalmic patient education materials. Surv Ophthalmol. 1997;42:152-156.
168. Ortiz F, Fitten LJ. Barriers to healthcare access for cognitively impaired older Hispanics. Alzheimer Dis Assoc Disord. 2000;14:141-150.
169. Weech-Maldonado R, Morales LS, Elliott M, Spritzer K, Marshall G, Hays RD. Race/ethnicity, language, and patients' assessments of care in Medicaid managed care. Health Serv Res. 2003; 38:789-808.
170. Xu KT, Rojas-Fernandez CH. Ancillary community pharmacy services provided to older people in a largely rural and ethnically diverse region: a survey of consumers in West Texas. J Rural Health. 2003;19:79-86.
171. John-Baptiste A, Naglie G, Tomlinson G, et al. The effect of English language proficiency on length of stay and in-hospital mortality. J Gen Intern Med. 2004;19:221-228.
172. Schillinger D, Piette J, Grumbach K, et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003;163:83-90.
173. Hussey LC. Minimizing effects of low literacy on medication knowledge and compliance among the elderly. Clin Nurs Res. 1994;3:132-145.
174. Mulrow C, Bailey S, Sonksen PH, Slavin B. Evaluation of an audiovisual diabetes education program: negative results of a randomized trial of patients with non-insulin-dependent diabetes mellitus. J Gen Intern Med. 1987;2:215-219.
175. Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant therapy. J Am Pharm Assoc. 2002;42:36-43.
176. Svarstad BL, Bultman DC, Mount JC, Tabak ER. Evaluation of written prescription information provided in community pharmacies: a study in eight states. J Am Pharm Assoc. 2003;43:383-393.
177. Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulations, pharmacist age, and busyness. J Am Pharm Assoc. 2004;44:22-29.
178. Sleath B, Chewning B, Svarstad B, Roter D. Patient expression of complaints and adherence problems with medications during chronic disease medical visits. J Soc Admin Pharm. 2000;17: 71-80.
179. Roter D. Advancing the physician's contribution to enhancing compliance. J Pharmacoepidemiol. 1995;3:37-48.
180. Haynes RB, McDonald PM, Garg AX. Helping patients follow prescribed treatment. JAMA. 2002; 288:2880-2883.
181. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383-386.
182. Haynes RB. Strategies for enhancing patient compliance. Drug Ther. 1980;January:147-154.
183. McDonald PM, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication regimens. JAMA. 2002;288:2868-2879.
184. Prochaska JO. Systems of Psychotherapy: A Transtheoretical Analysis. Homewood, Ill: Dorsey Press; 1979.
185. DiClemente CC, Prochaska JO. Self-change and therapy change of smoking behavior: a comparison of processes of change in cessation and maintenance. Addict Behav. 1982;7:133-142.
186. Prochaska JO, DiClemente CC. Common processes of self-change in smoking, weight control and psychological distress. In: Shiffman S, Wills, TA, eds. Coping and Substance Abuse. New York, NY: Academic Press; 345-363.
187. Norcross JC, Prochaska JO, DiClemente CC. Self-change of psychological distress: laypersons' vs psychologists' coping strategies. J Clin Psychol. 1986;42:834-840.
188. DiClemente CC, Hughes SO. Stages of change profiles in outpatient alcoholism treatment. J Subst Abuse. 1990;2:217-235.
189. Marcus BH, Banspach SW, Lefebvre RC, Rossi JS, Carleton RA, Abrams DB. Using the stages of change model to increase the adoption of physical activity among community participants. Am J Health Promot. 1992;6:424-429.
190. McConnaughy EA, Prochaska JO, Velicer WF. Stages of change in psychotherapy: measurement and sample profiles. Psychother Theory Res Pract. 1983;20:368-375.
191. Swanson AJ, Pantalon MV, Cohen KR. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. J Nerv Ment Dis. 1997;187:630-635.
192. Liang H. Decreasing Medication Dropout: A Study to Develop and Evaluate Intervention Software Using the Transtheoretical Model of Change and Motivational Interviewing [dissertation]. Auburn, Ala: Auburn University; 2003.
193. Noel OR. Adherence to Antihypertensive Medication Regimens: An Application of the Fishbein Behavioral Intention Model [dissertation]. Auburn, Ala: Auburn University; 1993.
194. Cattaneo MJ, Sengupta N, Nichol MB. Factors associated with compliance: analysis of the patient's health belief model. In: Program and abstracts of the ASHP midyear clinical meeting; December, 1999; Reno, Nev. Abstract P-444E.
195. Daftary MN, Goolsby T, Dutta A, Delapenha RA. Possible factors influencing non-adherence to antiretrovirals in an ambulatory HIV population. In: Program and abstracts of the ASHP midyear clinical meeting; December 2002; Atlanta, Ga. Abstract p 618E.
196. Magura S, Laudet AB, Mahmood D, Rosenblum A, Knight E. Adherence to medication regimens and participation in dual-focus self-help groups. Psychiatr Serv. 2002;53:310-316.